REQUEST A DEMO
Total
USD $0.00
Search more companies

Novopath, S.R.O. (Czech Republic)

Main Activities: Veterinary Services
Full name: Novopath, S.R.O. Profile Updated: November 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Novopath, S.R.O. is an enterprise in Czech Republic, with the main office in Ceperka. The enterprise currently operates in the Veterinary Services sector. It was incorporated on July 19, 2018. 10 - 19 (2024) employees currently work for Novopath, S.R.O.. In 2023, the company reported a net sales revenue increase of 11.62%. Its’ total assets recorded a growth of 33.78%. Novopath, S.R.O.’s net profit margin increased by 2.74% in 2023.

Headquarters
Vrchlickeho 230
Ceperka; Pardubicky; Postal Code: 53345

Contact Details: Purchase the Novopath, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Novopath, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Novopath, S.R.O. report to view the information.
Registered Capital:
Purchase the Novopath, S.R.O. report to view the information.
Incorporation Date:
July 19, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Novopath, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
11.62%
Total operating revenue
11.57%
Operating profit (EBIT)
24.38%
EBITDA
23.7%
Net Profit (Loss) for the Period
21.74%
Total assets
33.78%
Total equity
35.16%
Operating Profit Margin (ROS)
4.07%
Net Profit Margin
2.74%
Return on Equity (ROE)
-2.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?